Menu
Interim and final evaluation
Summary
Based on the EP, interim and final evaluations will be conducted as part of monitoring the EUCanScreen implementation and to assess progress towards specific objectives. In case of delays and other implementation challenges, direct consultation with relevant partners and/or stakeholders will be conducted. The subtasks will include data collection plan (3.3.1), SWOT analysis (3.3.2), data collection and cleaning (3.3.3) and monitoring (3.3.4). This task will be led by the UWK, Austria.
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
